Compounds > aripiprazole
Page last updated: 2024-08-24

aripiprazole and Late Onset Diseases

aripiprazole has been researched along with Late Onset Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blumberger, DM; Hsu, JH; Karp, JF; Lenze, EJ; Mulsant, BH; Reynolds, CF; Sanches, M1
Blumberger, DM; Hsu, JH; Karp, JF; Lavretsky, H; Lenze, EJ; Mulsant, BH; Reynolds, CF; Roose, SP1

Trials

2 trial(s) available for aripiprazole and Late Onset Diseases

ArticleYear
Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial.
    The Journal of clinical psychiatry, 2018, 06-19, Volume: 79, Issue:4

    Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Treatment-Resistant; Female; Humans; Late Onset Disorders; Male; Parkinson Disease, Secondary; Risk Factors; Time Factors

2018
Impact of Prior Treatment on Remission of Late-Life Depression with Venlafaxine and Subsequent Aripiprazole or Placebo Augmentation.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2016, Volume: 24, Issue:10

    Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Late Onset Disorders; Male; Middle Aged; Prognosis; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride

2016